At the same time, Keith Meister, managing partner and chief investment officer of the hedge fund Corvex Management, will take ...

Cathie Wood-led Ark Invest made notable trades, buying IRDM, BEAM, PACB, ABSI and selling ILMN, RPTX, AMGN, VEEV.

Illumina is estimated to have around 80% of the global DNA sequencing market, with Element one of a new generation of rivals alongside the likes of PacBio and Singular Genomics, which launched ...

Cathie Wood’s ARK ETFs have once again adjusted their portfolios, as revealed in the daily trade report for Thursday, March 27th, 2025. In a notable move, the ETFs sold a significant amount of ...

The Chinese government took its economic sanctions against San Diego-based Illumina a step further Tuesday by banning the gene-sequencing company from importing its machines to the country.

Burstein covers the Healthcare sector, focusing on stocks such as Pacific Biosciences, Agilent, and Exact Sciences. Currently, the analyst consensus on Illumina is a Hold with an average price ...

Cathie Wood's Ark Invest Scoops Up Iridium, Beam, Pacific Biosciences While Offloading Illumina And Amgen Cathie Wood-led Ark Invest made notable trades, buying IRDM, BEAM, PACB, ABSI and selling ...

According to a GlobalData market model, the top three NGS companies by global market share in 2024 were Illumina, Pacific Biosciences, and Thermo Fisher Scientific. Illumina holds a 34.5% market ...